World game at war: why some European nations have threatened a World Cup boycott 
Sony Eyes $1.3 Billion Tamron Acquisition as Lens Maker Reviews Offer 
Apple Stock Slides 7% as Weak Sales Forecast Overshadows Quarterly Earnings Beat 
Standard Chartered Beats Profit Forecasts as First-Half Earnings Rise 9% 
Arm Holdings Q1 Earnings Beat Estimates, Strong Q2 Outlook Fails to Lift ARM Stock 
Colgate-Palmolive Reaffirms 2026 Sales Outlook Despite Weak North America Demand 
Same sparkle, different story: how lab-grown diamonds are transforming the market 
Amazon Q2 Earnings Beat Estimates as AWS AI Growth Surges, But Q3 Revenue Forecast Disappoints 
SpaceX Wins $1.6 Billion U.S. Space Force Launch Contracts for Falcon 9 Missions Through 2027 
Meta-backed research finds exposure to ‘untrustworthy’ social media is rare. The fine print is less reassuring 
Anthropic Reveals Claude AI Accessed Real Production Systems During Cybersecurity Tests 
Meta Stock Drops After Earnings Miss as AI Spending and Legal Costs Weigh on Profit 
Microsoft Stock Jumps as Azure Growth, AI Revenue Beat Expectations 
Samsung Q2 Profit Surges on AI Memory Chip Demand, Forecasts Strong Second Half 
Japan Earthquake Disrupts Auto and Chip Supply Chains 
Starbucks Stock Jumps as Q3 Earnings Beat, Sales Growth Drives Higher 2026 Outlook 
Robinhood Q2 Earnings Beat Estimates, But HOOD Stock Falls as Investors Question Profit Quality 
BURLINGTON, Mass., May 03, 2018 -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will be presenting in three conferences in May.
David Roberts, President, is scheduled to present at the Deutsche Bank Healthcare Conference on Tuesday, May 8, 2018 at the InterContinental Hotel in Boston, MA. The Company’s presentation is scheduled to begin at 10:40 AM EDT.
George LeMaitre, Chairman & CEO, is scheduled to present at the East Coast IDEAS Conference on Wednesday, May 9, 2018 at the Boston Park Plaza Hotel in Boston, MA. The Company’s presentation is scheduled to begin at 11:10 AM EDT.
David Roberts, President, is scheduled to present at the UBS Healthcare Conference on Tuesday, May 22, 2018 at the Grand Hyatt New York Hotel in New York City. The Company’s presentation is scheduled to begin at 3:30 PM EDT.
About LeMaitre Vascular
LeMaitre Vascular is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. The Company's diversified product portfolio consists of brand name devices used in arteries and veins outside of the heart. Additional information can be found at www.lemaitre.com.
Contact: LeMaitre Vascular, Inc.
Investor Relations
Steven Chehames
+1-781-425-1659
[email protected]
